Cambridge, MA, United States of America

Thomas Christian Von Erlach

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Christian Von Erlach. Retrieved from https://idiyas.com/inventor/thomas-christian-von-erlach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Christian Von Erlach: Gastrointestinal Tissue Explant Innovation

Introduction

Thomas Christian Von Erlach is an inventor associated with Cambridge, Massachusetts. His patent work concerns gastrointestinal tissue explants and methods for preparing and using them.

Latest Patents

Von Erlach is credited with 1 patent: “Macro tissue explant, methods and uses therefor.” The invention describes tissue explants of the gastrointestinal tract, methods for making and using them, and substrates designed to support the explants.

Career Highlights

Von Erlach’s listed organizational affiliations include The Brigham and Women’s Hospital, Inc., and the Massachusetts Institute of Technology. His patent reflects work at the intersection of tissue research and methods for studying or using gastrointestinal tissue.

Collaborations

His listed coworkers include Sarah Saxton and Daniel Minahan.

Conclusion

Thomas Christian Von Erlach’s patent focuses on gastrointestinal tissue explants and the methods and substrates developed to support their preparation and use.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…